Ensign Peak Advisors »

BioCryst Pharmaceuticals shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $449k 88k 5.08
2023-09-30 $657k 93k 7.08
2023-06-30 $654k 93k 7.04
2023-03-31 $775k 93k 8.34
2022-12-31 $936k 82k 11.48
2022-09-30 $672k 53k 12.59
2022-06-30 $548k 52k 10.57
2022-03-31 $843k 52k 16.26
2021-12-31 $718k 52k 13.85